Quartesian Announces New Pharmacovigilance Offering

Quartesian is excited to announce a new offering: a suite of clinical trial data pharmacovigilance services. Our services for clinical research will include medical expertise throughout trial design and execution, enhancing a data-driven approach to clinical development. 

By adding pharmacovigilance and related medical monitoring services, we offer Sponsors deeper skills across a broad spectrum of diseases and technologies, including Oracle Argus, ARISg, AB Cube, RSS, and others. The new pharmacovigilance offerings include Safety Management Planning, Case Management, SAE Reconciliation, Literature Case Reporting and more, in either FSP or non FSP models.

To learn more and hear comments from Quartesian’s President and CEO, read the full press release here and follow us on Twitter at @Quartesian.

Contact us